April 2, 2014

Bloom Burton & Co. Launches New Website And Blog

Bloom Burton & Co. Launches New Website And Blog
/ Accelerating Returns in Healthcare
TORONTO, ON / ACCESSWIRE / April 2, 2014 / Bloom Burton & Co., a firm dedicated to accelerating returns in healthcare (“Bloom Burton” or the “Company”), announces today the launch of its new corporate website and blog at www.bloomburton.com.
Brian Bloom, President of the Company, said, “We are excited to unveil our new website, which describes and illustrates, including through detailed case studies, our full suite of services that assist our clients in pursuing the appropriate monetizing events. Our firm offers services that include capital raising, M&A advisory, equity research, scientific, medical and strategic consulting, as well as opportunities for investors to participate in healthcare investing through equity and debt funds, which are sub-advised by one of our affiliated companies. I encourage you to learn more by visiting our new website.”
The Bloom Burton team has been dedicated exclusively to the healthcare investment industry for more than a decade and because of the team’s deep expertise and experience in the healthcare sector Bloom Burton’s clients may achieve a faster path to their monetizing events. Bloom Burton works with institutional investors looking to invest in the healthcare sector and with healthcare companies and organizations of all sizes and stages of development that are seeking advice or capital.
All of Bloom Burton’s services rest upon a disciplined methodology of performing deep due diligence on healthcare assets, considering the widest range of solutions – both for a transaction path and across multiple jurisdictions, engaging healthcare-specialist investors and strategic companies that provide insight and validation to drive value, and performing all of our work with the tenacity and creativity of an entrepreneurial firm. Bloom Burton also acts as a hub for the broader healthcare industry in Canada, which in addition to companies and investors, includes government agencies, universities, academic researchers, technology transfer organizations and multinational companies, and with this in mind, the Company announces today the launch of the Bloom Burton Cross-Border Biotech Blog, which can be found at www.bloomburton.com/blog. The Blog will feature commentary and opinions from executives of leading companies in the biotechnology and healthcare sector, specialist institutional investors and individuals who shape the healthcare industry in Canada and elsewhere in the world. Jolyon Burton, CEO of Bloom Burton, said “Our highly specialized and talented team provides our clients with insight, which is always backed up with an evidence-based approach. We continue to build our Company and we are excited about the future of our sector. Today’s launch of our new website and Bloom Burton’s Cross-Border Biotech Blog reflects a significant milestone in the growth of our platform and service offerings because we now have an exceptional team of professionals that have chosen to partner with us and help our clients choose the appropriate monetization strategies.”
About Bloom Burton & Co.
Bloom Burton & Co. is a firm dedicated to accelerating monetization for both investors and companies alike in the healthcare sector. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with a creative and entrepreneurial approach, assists to lead to our clients to the appropriate monetization events. The Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and product development consulting services, and also creates and incubates new biotechnology and healthcare companies. Please visit www.bloomburton.com to learn more.   The website does not constitute an offer to sell or solicitation to purchase securities of, or any endorsement of, any issuer or any portfolio set out therein and/or sub-advised by any Bloom Burton company. The website is not intended to provide advice of any kind, including without limitation, investment, financial or legal advice. The information contained on the website is for information purposes only and is subject to change without notice. Bloom Burton does not accept any liability for the use of the website. The website is provided on an “as is” and “as available” basis, without any representations, warranties or conditions of any kind, whether express or implied, and including, without limitation, implied representations, warranties or conditions of non-infringement, merchantability, fitness for a particular purpose, performance, availability, timeliness, accuracy, or completeness, all of which are hereby disclaimed by Bloom Burton to the fullest extent permitted by law. Bloom Burton will not under any circumstances be liable for any loss or damage arising from, connected with, or relating to the use of, or inability to use, the website or the information, or any action or decision made by any person in reliance on the website or the information, or any unauthorized use or reproduction of the website or the information. Bloom Burton shall not be responsible or liable for any damages incurred to computer equipment or other types of equipment used nor for viruses that may infect the former due to the access and use of the website or the downloading of any document or materials from the website.
For more information, please contact:
Brian Bloom
President, Bloom Burton & Co.
65 Front Street East, Suite 300
Toronto, Ontario  M5E 1B5
(416) 640-7575
SOURCE: Bloom Burton & Co.